JPRN-UMIN000037503已完成未知
HEMLIBRA Subcutaneous injection Special Drug Use Surveillance (with Hemophilia A without Inhibitors). - HEMLIBRA Special Drug Use Surveillance (with Hemophilia A without Inhibitors).
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 87
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No criteria
研究者
相似试验
招募中
不适用
HEMLIBRA Subcutaneous injection General Drug Use Surveillance(in Hemophilia A with Inhibitors).Hemophilia AJPRN-UMIN000032515Chugai Pharmaceutical Co. Ltd.100
招募中
不适用
HEMLIBRA Subcutaneous Injection, General drug use-results survey - Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia ARoutine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia AJPRN-UMIN000048156Chugai Pharmaceutical Co. Ltd.150
招募中
Unknown
EPKINLY Subcutaneous Injection General use-results surveillance (All case): OBSC3013-39D-ERelapsed or refractory large B-cell lymphoma and relapsed or refractory follicular lymphomaJPRN-jRCT2031230525Genmab K.K. Drug safety and pharmacovigilance250
招募中
2 期
effects of rituximab in patients with pemphigus vulgaris with oral lesionsIRCT20240604062002N1Tabriz University of Medical Sciences20
已完成
不适用
The therapeutic effect of intradermal injection of Measles, Mumps, and Rubella vaccine in treatment of palmoplantar warts in patients unresponsive to treatmentIRCT2016101027636N3Vice chancellor for Research of Mazandaran University of Medical Sciences60